• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Edema (1820); Erythema (1840); Hemorrhage/Bleeding (1888); Blood Loss (2597)
Event Date 08/31/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
It was reported that the patient was admitted on (b)(6) 2020 for fluid overload and decreased hemoglobin (hgb).The patient also noted to have some erythema around the driveline.The patient diuresed on lasix drip for fluid overload.Gastroenterology (gi) consulted for melena, planned for tagged red blood cells (rbcs) study.Study completed (b)(6) 2020 with no acute findings.Resumed coumadin (b)(6) 2020.Plan for international normalized ratio (inr) to trend up slowly without bridge.Intravenous (iv) iron replacement given and the patient was able to discharge home on (b)(6) 2020.No further information was provided.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between heartmate 3 left ventricular assist system (lvas), serial number mlp-012780, and the reported gastrointestinal (gi) bleeding, fluid overload, and erythema could not be conclusively determined through this evaluation.It was reported that the patient was admitted on (b)(6) 2020 for fluid overload and decreased hemoglobin.Erythema was also noted around the driveline.The fluid overload was treated with medication for diuresis.Melena was also reported, and a tagged red blood cell study was completed on (b)(6) 2020 with no acute findings.Anticoagulation medication was resumed on (b)(6) 2020 and an intravenous (iv) iron replacement was given.The plan was to trend the patient¿s international normalized ratio (inr) up slowly, and the patient was discharged home on (b)(6) 2020.The patient ultimately expired on 12feb2021 after declining intravenous (iv) antibiotics for an infection, and voluntarily turning the left ventricular assist device (lvad) off after a period of declining health in home hospice (refer to manufacturer report number 2916596-2021-01014).The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu), rev.C is currently available.Section 1 of this document lists bleeding as adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6 ¿patient care and management¿ (under "anticoagulation") outlines the recommended anticoagulation regimen (including inr range) for patients using the heartmate 3 lvas as well as the suggested anticoagulation modifications in the event that there is a risk of bleeding.The relevant sections of the device history records for mlp-012780 were reviewed and showed no deviations from manufacturing or quality assurance specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11017098
MDR Text Key221770464
Report Number2916596-2020-05946
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/26/2021
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number6693729
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age70 YR
Patient Weight89
-
-